Patent Assignment
Reel/Frame 063868/0452
Assignment of Assignor's Interest
Recorded: 2023-06-06
Pages: 10
Assignors
JAIN, PARAS P.
Executed: 2022-11-30
LAKSHMIPATHULA, KRISHNA MOHAN
Executed: 2022-11-30
NAVGIRE, SOMNATH DEVIDAS
Executed: 2022-11-30
BAPATU, HANIMI REDDY
Executed: 2022-11-30
JAIN, SANDEEP
Executed: 2022-11-30
PILLAI, SUMITRA ASHOKKUMAR
Executed: 2022-11-30
SUBBAPPA, PRAVEEN KUMAR
Executed: 2022-11-30
Assignee
SLAYBACK PHARMA LLC
301 CARNEGIE CENTER, SUITE 303, PRINCETON, NEW JERSEY, 08540
Covered Property
(1)
Modified-Release Dosage Forms of Ruxolitinib
Application:
18/075,150 →
Publication:
US 2023/0172863
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Sep 27, 2023
From: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065045/0560 →
Release of Security Interest
Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →